seattle wellness programs semaglutide Ozempic Weight Loss Injections in Semaglutide Weight Loss in Seattle:

I also spoke to a young man and he was excellent handling my case as well

But in 2023, the Food and Drug Administration rightly moved peptides to a no-compounding-allowed status called Category 2 due to concerns about safety and lack of clinical trial data

47 warning letters issued to compounding pharmacies (October 2025 - March 2026) [6] 68% of violations: Continued compounding after shortage resolution 54% of violations: Supplemental ingredients not in approved formulations 31% of violations: Inadequate sterility testing protocols 26% of violations: Marketing claims implying bioequivalence 45% decrease in compounded GLP-1 volume since October 2025 [8] What This Means for Research Procurement The FDA compounding crackdown does not directly affect research peptide procurement

1600 1600